Tudor Investment Corp’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,636
| Closed | -$11.8M | – | 4319 |
|
|
2025
Q4 | $11.5M | Sell |
23,636
-3,931
| -14% | -$1.83M | 0.02% | 657 |
|
|
2025
Q3 | $11.6M | Buy |
+27,567
| New | +$9.27M | 0.02% | 693 |
|
|
2025
Q1 | – | Sell |
-22,387
| Closed | -$7.9M | – | 3707 |
|
|
2024
Q4 | $7.9M | Buy |
22,387
+13,041
| +140% | +$4.79M | 0.03% | 463 |
|
|
2024
Q3 | $3.35M | Buy |
+9,346
| New | +$3.16M | 0.01% | 919 |
|
|
2024
Q1 | – | Sell |
-20,084
| Closed | -$4.42M | – | 2821 |
|
|
2023
Q4 | $4.42M | Buy |
+20,084
| New | +$4.63M | 0.04% | 701 |
|
|
2022
Q3 | – | Sell |
-3,272
| Closed | -$771K | – | 2737 |
|
|
2022
Q2 | $771K | Buy |
+3,272
| New | +$665K | 0.02% | 1031 |
|
|
2020
Q3 | – | Sell |
-5,672
| Closed | -$686K | – | 1563 |
|
|
2020
Q2 | $686K | Buy |
+5,672
| New | +$638K | 0.03% | 612 |
|
|
2020
Q1 | – | Sell |
-36,171
| Closed | -$3.19M | – | 1355 |
|
|
2019
Q4 | $3.19M | Buy |
36,171
+21,657
| +149% | +$1.91M | 0.14% | 163 |
|
|
2019
Q3 | $1.16M | Sell |
14,514
-39,426
| -73% | -$3.18M | 0.04% | 451 |
|
|
2019
Q2 | $4.21M | Buy |
+53,940
| New | +$5.04M | 0.12% | 122 |
|
|
2019
Q1 | – | Sell |
-7,718
| Closed | -$840K | – | 1285 |
|
|
2018
Q4 | $840K | Sell |
7,718
-7,604
| -50% | -$882K | 0.02% | 446 |
|
|
2018
Q3 | $1.96M | Buy |
15,322
+4,616
| +43% | +$571K | 0.05% | 285 |
|
|
2018
Q2 | $1.21M | Buy |
+10,706
| New | +$1.18M | 0.04% | 377 |
|
|
2018
Q1 | – | Sell |
-4,085
| Closed | -$604K | – | 1259 |
|
|
2017
Q4 | $604K | Sell |
4,085
-3,692
| -47% | -$469K | 0.02% | 528 |
|
|
2017
Q3 | $911K | Buy |
+7,777
| New | +$993K | 0.02% | 429 |
|
|
2017
Q2 | – | Sell |
-3,700
| Closed | -$501K | – | 1390 |
|
|
2017
Q1 | $501K | Buy |
3,700
+166
| +5% | +$25.1K | 0.02% | 686 |
|
|
2016
Q4 | $507K | Sell |
3,534
-6,570
| -65% | -$839K | 0.01% | 721 |
|
|
2016
Q3 | $1.19M | Buy |
10,104
+6,404
| +173% | +$769K | 0.03% | 336 |
|
|
2016
Q2 | $392K | Sell |
3,700
-900
| -20% | -$100K | 0.01% | 1005 |
|
|
2016
Q1 | $513K | Buy |
4,600
+1,700
| +59% | +$215K | 0.01% | 927 |
|
|
2015
Q4 | $454K | Buy |
+2,900
| New | +$422K | 0.01% | 960 |
|
|
2015
Q3 | – | Sell |
-7,375
| Closed | -$1.28M | – | 1767 |
|
|
2015
Q2 | $1.28M | Buy |
7,375
+5,575
| +310% | +$1M | 0.04% | 323 |
|
|
2015
Q1 | $310K | Sell |
1,800
-600
| -25% | -$91.5K | 0.01% | 1030 |
|
|
2014
Q4 | $311K | Sell |
2,400
-619
| -21% | -$79.8K | 0.01% | 1022 |
|
|
2014
Q3 | $388K | Sell |
3,019
-5,149
| -63% | -$531K | 0.01% | 834 |
|
|
2014
Q2 | $723K | Sell |
8,168
-999
| -11% | -$96.1K | 0.03% | 345 |
|
|
2014
Q1 | $862K | Buy |
9,167
+4,067
| +80% | +$416K | 0.04% | 254 |
|
|
2013
Q4 | $577K | Sell |
5,100
-2,600
| -34% | -$234K | 0.03% | 460 |
|
|
2013
Q3 | $607K | Sell |
7,700
-7,900
| -51% | -$577K | 0.03% | 262 |
|
|
2013
Q2 | $1.03M | Buy |
+15,600
| New | +$1M | 0.08% | 122 |
|
Other funds holding UTHR
ACA
VPM
VCM
Tudor Investment Corp's UTHR Position: Q1 2026 in Review
Tudor Investment Corp sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 23,636 shares — an estimated $11.8M sold.
Tudor Investment Corp first reported a position in UTHR in Q2 2013 and held it in 30 quarters. The position peaked at $11.6M in Q3 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Tudor Investment Corp reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Tudor Investment Corp sold 23,636 United Therapeutics shares in Q1 2026, an estimated $11.8M.
- Tudor Investment Corp first reported a position in United Therapeutics in Q2 2013 and held it in 30 quarters.
- Tudor Investment Corp's United Therapeutics position peaked at $11.6M in Q3 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.